BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 14987380)

  • 1. Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategies.
    Saraiva MJ
    Expert Rev Mol Med; 2002 May; 4(12):1-11. PubMed ID: 14987380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and biochemical findings of thyroid amyloid in hereditary transthyretin amyloidosis with and without liver transplantation.
    Huang G; Ueda M; Tasaki M; Yamashita T; Misumi Y; Masuda T; Suenaga G; Inoue Y; Kinoshita Y; Matsumoto S; Mizukami M; Tsuda Y; Nomura T; Obayashi K; Ando Y
    Amyloid; 2017 Mar; 24(1):24-29. PubMed ID: 28081656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation.
    Liepnieks JJ; Benson MD
    Amyloid; 2007 Dec; 14(4):277-82. PubMed ID: 17968687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin-related hereditary amyloidosis in a Chinese family with TTR Y114C mutation.
    Zhang Y; Deng YL; Ma JF; Zheng L; Hong Z; Wang ZQ; Sheng CY; Xiao Q; Cao L; Chen SD
    Neurodegener Dis; 2011; 8(4):187-93. PubMed ID: 21135536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin amyloidosis: a tale of weak interactions.
    Saraiva MJ
    FEBS Lett; 2001 Jun; 498(2-3):201-3. PubMed ID: 11412857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis.
    Lim A; Prokaeva T; McComb ME; Connors LH; Skinner M; Costello CE
    Protein Sci; 2003 Aug; 12(8):1775-85. PubMed ID: 12876326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aged vervet monkeys developing transthyretin amyloidosis with the human disease-causing Ile122 allele: a valid pathological model of the human disease.
    Ueda M; Ageyama N; Nakamura S; Nakamura M; Chambers JK; Misumi Y; Mizuguchi M; Shinriki S; Kawahara S; Tasaki M; Jono H; Obayashi K; Sasaki E; Une Y; Ando Y
    Lab Invest; 2012 Mar; 92(3):474-84. PubMed ID: 22184092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis.
    Ihse E; Ybo A; Suhr O; Lindqvist P; Backman C; Westermark P
    J Pathol; 2008 Oct; 216(2):253-61. PubMed ID: 18729067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis.
    Gustavsson A; Jahr H; Tobiassen R; Jacobson DR; Sletten K; Westermark P
    Lab Invest; 1995 Nov; 73(5):703-8. PubMed ID: 7474944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategies.
    Damas AM; Saraiva MJ
    J Struct Biol; 2000 Jun; 130(2-3):290-9. PubMed ID: 10940233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis.
    Ihse E; Rapezzi C; Merlini G; Benson MD; Ando Y; Suhr OB; Ikeda S; Lavatelli F; Obici L; Quarta CC; Leone O; Jono H; Ueda M; Lorenzini M; Liepnieks J; Ohshima T; Tasaki M; Yamashita T; Westermark P
    Amyloid; 2013 Sep; 20(3):142-50. PubMed ID: 23713495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Synuclein aggregation in the saliva of familial transthyretin amyloidosis: a potential biomarker.
    Guerreiro A; da Costa G; Gomes RA; Ribeiro-Silva C; Gilberto S; Mateus E; Monteiro E; Barroso E; Coelho AV; Ponces Freire A; Cordeiro C
    Amyloid; 2012 Jun; 19(2):74-80. PubMed ID: 22591216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary transthyretin amyloidosis from a Scandinavian perspective.
    Suhr OB; Svendsen IH; Andersson R; Danielsson A; Holmgren G; Ranløv PJ
    J Intern Med; 2003 Sep; 254(3):225-35. PubMed ID: 12930231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity.
    Ferreira N; Cardoso I; Domingues MR; Vitorino R; Bastos M; Bai G; Saraiva MJ; Almeida MR
    FEBS Lett; 2009 Nov; 583(22):3569-76. PubMed ID: 19861125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel variant of transthyretin, 59Thr-->Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family.
    Booth DR; Tan SY; Hawkins PN; Pepys MB; Frustaci A
    Circulation; 1995 Feb; 91(4):962-7. PubMed ID: 7850982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse model of a novel missense mutation (Gly83Arg) in a Chinese kindred manifesting vitreous amyloidosis only.
    Ran LX; Zheng ZY; Xie B; Nie XM; Chen XW; Su G; Cai SJ
    Exp Eye Res; 2018 Apr; 169():13-19. PubMed ID: 29360446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid fibril composition as a predictor of development of cardiomyopathy after liver transplantation for hereditary transthyretin amyloidosis.
    Gustafsson S; Ihse E; Henein MY; Westermark P; Lindqvist P; Suhr OB
    Transplantation; 2012 May; 93(10):1017-23. PubMed ID: 22395298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cerebral amyloid angiopathy with familial transthyretin-derived oculoleptomeningeal amyloidosis].
    Ikeda SI
    Brain Nerve; 2013 Jul; 65(7):831-42. PubMed ID: 23832986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clusterin regulates transthyretin amyloidosis.
    Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
    Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.